Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects humans and animals which make coronavirus disease 2019 (COVID-19) a grievous epidemic worldwide which broke out in 2020. According to data analysis of the other coronavirus family, for instance severe acute respiratory...

Full description

Bibliographic Details
Main Authors: Zhi-Mei Liu, Ming-Hui Yang, Kun Yu, Zheng-Xing Lian, Shou-Long Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
TLRs agonists
TLRs antagonists
COVID-19 infection
innate immunity
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.989664/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.989664/full

Similar Items